311 related articles for article (PubMed ID: 35289862)
1. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
[TBL] [Abstract][Full Text] [Related]
2. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Artificial Intelligence for Proximal Caries Detection.
Schwendicke F; Rossi JG; Göstemeyer G; Elhennawy K; Cantu AG; Gaudin R; Chaurasia A; Gehrung S; Krois J
J Dent Res; 2021 Apr; 100(4):369-376. PubMed ID: 33198554
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of AI for caries detection: randomized trial.
Schwendicke F; Mertens S; Cantu AG; Chaurasia A; Meyer-Lueckel H; Krois J
J Dent; 2022 Apr; 119():104080. PubMed ID: 35245626
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence for Caries Detection: Value of Data and Information.
Schwendicke F; Cejudo Grano de Oro J; Garcia Cantu A; Meyer-Lueckel H; Chaurasia A; Krois J
J Dent Res; 2022 Oct; 101(11):1350-1356. PubMed ID: 35996332
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
Wolf RM; Channa R; Abramoff MD; Lehmann HP
JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling.
Dorali P; Shahmoradi Z; Weng CY; Lee T
Ophthalmol Retina; 2023 Jun; 7(6):532-542. PubMed ID: 36621610
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Dental Workforce Expansion Through the National Health Service Corps and Its Association With Oral Health Outcomes Among US Children.
Choi SE; Shen Y; Wright DR
JAMA Health Forum; 2023 Mar; 4(3):e230128. PubMed ID: 36930167
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of school-based caries screening using transillumination.
Schwendicke F; Bombeck L
J Dent; 2023 Oct; 137():104635. PubMed ID: 37541420
[TBL] [Abstract][Full Text] [Related]
14. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
[TBL] [Abstract][Full Text] [Related]
15. Economic Evaluation of Artificial Intelligence Systems Versus Manual Screening for Diabetic Retinopathy in the United States.
Chawla H; Uhr JH; Williams JS; Reinoso MA; Weiss JS
Ophthalmic Surg Lasers Imaging Retina; 2023 May; 54(5):272-280. PubMed ID: 37078827
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.
Ming S; Xie K; Lei X; Yang Y; Zhao Z; Li S; Jin X; Lei B
Int Ophthalmol; 2021 Apr; 41(4):1291-1299. PubMed ID: 33389425
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence applications in restorative dentistry: A systematic review.
Revilla-León M; Gómez-Polo M; Vyas S; Barmak AB; Özcan M; Att W; Krishnamurthy VR
J Prosthet Dent; 2022 Nov; 128(5):867-875. PubMed ID: 33840515
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
